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 2 
Abstract  1 
Objectives: To examine the effect of  walking and vitamin B supplementation on quality-of-life (QoL) 2 
in community-dwelling adults with mild cognitive impairment. 3 
Methods: One year, double-blind, placebo-controlled trial. Participants were randomized to: 1) twice-4 
weekly, group-based, moderate-intensity walking program (n=77) or a light-intensity placebo activity 5 
program (n=75); and 2) daily vitamin B pills containing 5 mg folic acid, 0.4 mg B12, 50 mg B6 (n=78) 6 
or placebo pills (n=74). QoL was measured at baseline, after six and 12 months using the population-7 
specific Dementia Quality-of-Life (D-QoL) to assess overall QoL and the generic Short-Form 12 8 
mental and physical component scales (SF12-MCS and SF12-PCS) to assess health-related QoL. 9 
Results: Baseline levels of QoL were relatively high. Modified intention-to-treat analyses revealed no 10 
positive main intervention effect of walking or vitamin supplementation. In both men and women, 11 
ratings of D-QoL-belonging and D-QoL-positive affect subscales improved with 0.003 (p=0.04) and 12 
0.002 points (p=0.06) with each percent increase in attendance to the walking program. Only in men, 13 
SF12-MCS increased with 0.03 points with each percent increase in attendance (p=0.08).  14 
Conclusion: Several small but significant improvements in QoL were observed with increasing 15 
attendance to the walking program. No effect of vitamin B supplementation was observed.  16 
Trial Registration: International Standard Randomized Controlled Trial Number Register, 19227688, 17 
http://www.controlled-trials.com/isrctn/. 18 
Keywords: quality of life, aged, exercise, dietary supplements, randomized controlled trial.   19 
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 3 
Introduction  1 
Especially in older people, both mental and physical function decrease due to multiple age related 2 
changes, which in turn may affect quality of life (QoL). The most obvious decrease in mental function 3 
is cognitive decline, which is a common aspect of aging. However, in some cases decline is more 4 
serious than expected for a certain age. This is specified as Mild Cognitive Impairment (MCI). MCI is 5 
considered to be a potential transitional stage between normal cognitive function and Alzheimer’s 6 
disease, characterized by 1) subjective memory complaint 2) objective memory impairment 3) normal 7 
mental status 4) intact activities of daily living (ADL) 5) absence of dementia [1]. Independent of the 8 
latter four criteria, subjective memory complaints are related to lower QoL [2]. Moreover, MCI is 9 
associated with poor physical health and high risk of ADL dependence [3, 4]. Since both cognitive and 10 
physical decline belong to the most important determinants of QoL in community dwelling elderly 11 
subjects [5], subjects with MCI are likely to be susceptible to a decrease in QoL.  12 
 13 
The number of adults with MCI is increasing considerably due to the aging population. For multiple 14 
reasons, it is important to prevent a decrease in QoL. Apart from the personal benefits, a high rated 15 
QoL also reduces medical consumption and helps to maintain independency as long as possible [6]. 16 
This in turn may relieve significant others, caregivers and medical society in general. For this reason, 17 
attention should be paid to possible interventions contributing towards a higher level of overall QoL 18 
and it’s mental and physical components. In this respect, physical exercise and vitamin 19 
supplementation are interesting interventions worth investigating. Regular participation in moderate 20 
intensity aerobic training is reported to be beneficial in improving QoL and wellbeing, which is an 21 
important aspect of QoL [7, 8]. Since walking is the most prevalent physical activity among older 22 
adults [9], improving QoL by increasing the time spent on moderate intensity walking seems 23 
promising. Indeed, a community based walking program significantly improved both the physical and 24 
mental components of health-related QoL in older adults (n=582) [10]. Inconclusive evidence has been 25 
reported on the influence of vitamin B supplementation on QoL. Different aspects of QoL were not 26 
responsive to short term supplementation (range 4-12 weeks) with different doses and combinations 27 
of B vitamins in men and women [11-13].  28 
 29 
Not much is known about QoL in community dwelling elderly with MCI. Moreover, no trials on the 30 
effect of exercise and vitamin B supplementation on QoL have been carried out yet in adults with MCI. 31 
 4 
The FACT-study (Folate physical Activity Cognition Trial) was developed to examine the effect of 1 
these interventions on cognition [14]. Aspects of QoL were measured as a secondary outcome. In the 2 
present paper, the effectiveness of one year moderate intensity walking (two sessions of 60 minutes 3 
per week) and daily vitamin supplementation (5 mg folate, 50 mg vitamin B6 and 0.4 mg B12) on both 4 
overall QoL and it’s health-related components is examined in community dwelling older adults with 5 
MCI. We hypothesize that one year moderate intensity walking benefits QoL. Concerning the effect of 6 
vitamin supplementation, this paper should be considered as explorative. 7 
 8 
Methods 9 
Study design  10 
The study was designed as a randomized, placebo controlled intervention trial, based on a two-by-two 11 
factorial design. The study-protocol has been described in detail elsewhere [15] and was approved by 12 
the VU University Medical Center medical ethics committee. Written informed consent was obtained 13 
from all participants.  14 
 15 
Participants  16 
In a medium-sized Dutch town community dwelling subjects aged 70 to 80 years with MCI were 17 
identified using a population based two-step-screening [16]. The operational criteria for MCI according 18 
to the criteria of Petersen et al. [1] and additional inclusion criteria for the RCT are described in table 19 
1. Subjects were not paid to participate in the study.  20 
 21 
Insert Table 1 around here 22 
 23 
Randomization  24 
After the baseline interview, subjects were randomly assigned to the interventions using the statistical 25 
computer program SPSS. Intervention groups were: 1) walking program or placebo activity program; 26 
and 2) vitamin B supplementation or placebo supplementation. Randomization was stratified for 27 
physical activity level at baseline in minutes per day as measured by the LASA physical activity 28 
questionnaire [17]. For the flow of participants see figure 1. 29 
 30 
Insert Figure 1 around here 31 
 5 
Exercise intervention 1 
Subjects assigned to the walking program (WP) participated twice a week 60 minutes in group-based 2 
moderate intensity walking during one year. Each session consisted of a warming up, moderate 3 
intensity walking exercises and a cooling down. The WP was based on ‘Sportive Walking’, an existing 4 
aerobic walking program [18] aimed at improving cardiovascular endurance. Therefore, duration and 5 
intensity of the walking exercises increased gradually during the program. Sessions took place 6 
outdoor in municipal parks. Subjects not assigned to the WP participated in a placebo activity program 7 
(PAP) with the same frequency, session duration and program duration. However, the PAP consisted 8 
of low intensity exercise, such as light range of motion movements and stretching. Sessions were 9 
divided into five themes: relaxation, activities of daily living, balance, flexibility, posture and a 10 
combination of all. For each theme three sessions were developed and the entire series of 18 11 
sessions was repeated during the intervention period. The PAP was carried out in community centers. 12 
Both programs were supervised by qualified and trained instructors. Attendance to both programs was 13 
assessed by the percentage of attended sessions. 14 
 15 
Vitamin supplementation (FA/B12/B6) 16 
Subjects in the vitamin supplementation group took one pill containing 5 mg vitamin B11 (Folic Acid), 17 
0.4 mg vitamin B12 (Cyanocobalamin) and 50 mg vitamin B6 (Pyridoxine-hydrochloride) daily during 18 
one year. This vitamin supplement is available on prescription in The Netherlands. Subjects 19 
randomized to the control group took an identically looking placebo pill. The pills were packed in blister 20 
packs for one week, which were labeled for each day of the week. Compliance with the vitamin 21 
supplementation was verified by pill counts in returned blister packs during the intervention. 22 
 23 
Outcome measures 24 
Baseline data on sociodemographic and background variables were collected using a postal screening 25 
questionnaire. The measurement of other baseline variables, as reported in table 2, has been 26 
described elsewhere [15]. In the present manuscript a distinction was made between ‘overall quality of 27 
life’, referring to a subjects overall enjoyment of life and ‘health-related quality of life’, referring to 28 
health- related factors affecting quality of life. The term QoL was used as an umbrella term for both 29 
overall and health-related QoL. The population-specific Dementia Quality of Life questionnaire (D-30 
QoL) [19] was used to assess overall QoL and the generic Short Form 12 (SF12) [20] to assess 31 
 6 
health-related QoL. The D-QoL is a 29 item measure especially developed for elderly with cognitive 1 
decline and dementia. The participant is asked about how much they enjoyed activities that were 2 
reported to be important for elderly such as ‘watching animals’. Moreover, the frequency of certain 3 
positive and negative feelings such as ‘lovable’ or ‘worried’ were asked for. Finally, they were asked to 4 
rate their overall quality of life. The participant was instructed to choose the best fitting answer from 5 
five item response scales. The answers were divided into five domains of QoL measuring sense of 6 
aesthetics, feelings of belonging, negative affect, positive affect/humor and self esteem. A mean score 7 
ranging from one to five was calculated for these subscales and for the total D-QoL. A higher score 8 
indicated better quality of life. Median internal consistency reliability of the D-QoL was 0.80 and 9 
median test-retest reliability was 0.72 in a sample of 95 older adults with different stages of cognitive 10 
decline [19]. The SF12 consists of twelve items measuring eight concepts of both mental and physical 11 
health, i.e. physical functioning, role-physical, bodily pain, general health, energy, social functioning, 12 
role emotional and mental health. These concepts are subdivided into two summary scores using a 13 
norm-based criterion: i.e. mental and physical component summary scales (SF12-MCS and SF12-14 
PCS). The mean score is 50 with a standard deviation of ten. For example, a score of 60 corresponds 15 
to a -QoL rating of one standard deviation above the average ratings in the general population. Test 16 
retest reliability for the SF-12 MCS was 0.76 in a sample of 187 adults in the United Kingdom and 0.77 17 
in a sample of 232 adults in the United States. Reliability coefficients of the SF-12 PCS in these 18 
populations were 0.86 and 0.89 respectively [20]. In the present study, measurement took place 19 
during a personal interview at baseline and after 6 and 12 months. Both the D-QoL and the SF-12 20 
were administered by a trained interviewer who was unaware of the participants’ group allocation.  21 
 22 
Statistical analyses 23 
Differences between groups on baseline characteristics were tested using independent t-tests 24 
(normally distributed variables), Mann Whitney U tests (not normally distributed variables) and chi-25 
square (categorical variables). Within group differences were tested using dependent t-tests.  26 
 27 
Subsequently, data were analyzed according to a modified intention-to-treat principle, based on data 28 
from all randomized participants who provided data at baseline and at least one follow-up 29 
measurement. To evaluate the effects of the walking program and the vitamin supplementation on 30 
QoL, longitudinal regression analysis was used. The two follow-up measurements were defined as 31 
 7 
dependent variable and multi level analysis with two levels was used, 1) time of follow-up 1 
measurement (values corresponding with performance after six and 12 months intervention); 2) 2 
individual. According to the study protocol [15], the effect of both interventions was examined 3 
independently from each other. Data were analyzed using a crude and an adjusted model. 4 
Independent variables were exercise intervention and vitamin intervention. By analyzing both 5 
interventions in the same model, results were adjusted for the possible influence of the other 6 
intervention. Moreover, all analyses were adjusted for baseline performance on the outcome measure 7 
by adding this as a covariate. In the adjusted model, education, baseline activity level, baseline 8 
vitamin status, attendance to the exercise program and compliance with the supplementation were 9 
added as covariates. Interaction between gender and the WP or FA/B6/B12-supplementation was 10 
checked in the adjusted model. In the case of significant interaction, results were reported for men and 11 
women separately. In the case of no interaction, gender was added to the adjusted model as an 12 
additional covariate. Also, in the ‘adjusted model’ an interaction effect of the exercise program with 13 
attendance to the exercise program was checked. Finally, data were analyzed according to the per 14 
protocol principle, including all participants who attended at least 75 percent of the sessions. This cut-15 
off point is in concordance with previous exercise intervention studies in older adults [21, 22].  16 
 17 
Data were analyzed using SPSS for Windows (release 12.0.1). A significance level of five percent was 18 
used for between group comparisons and of ten percent for interaction terms. For all analyses, 19 
regression coefficients and 95% confidence intervals for the adjusted models were reported, with the 20 
regression coefficients directly indicating the difference in QoL ratings between the WP and the PAP 21 
or the FA/B12/B6-supplementation versus placebo supplementation. In the case of significant 22 
interaction, regression coefficients and the 95 percent confidence intervals of the interaction terms 23 
were reported. 24 
 25 
Results  26 
Patient characteristics 27 
Hundred-seventy-nine participants were randomized to the interventions. Twenty-seven of them were 28 
excluded from the analyses, because they only provided baseline data. These subjects were more 29 
often married (71 versus 52 percent, p=0.05) and less often current smokers (0 versus 14 percent, 30 
p=0.04) than the remaining 152 participants who provided QoL data at baseline and at at least one 31 
 8 
follow-up measurement. The latter 152 participants were included in the analyses (see figure one). 1 
Their mean age (SD) was 75 (2.9) years. Fifty-six percent was male. Additional baseline variables are 2 
described in table 2. Baseline variables were compared according to factor; subjects in the walking 3 
group  (W-group and W+V-group) were compared to subjects in the placebo activity program (V-group 4 
and C-group) and subjects in the FA/B12/B6 supplementation group (V-group and W+V-group) were 5 
compared to subjects in the placebo supplementation group (W-group and C-group). Compared to the 6 
PAP, the WP included fewer men (48% in WP versus 64% in PAP) and more subjects with 7 
hypertension (27% in WP versus 14% in PAP). Ratings for both overall and health-related QoL at 8 
baseline and after six and twelve months intervention are presented in table 3. No baseline differences 9 
were observed on these measures, except for a higher rating of D-QoL self-esteem in subjects in the 10 
FA/B12/B6-group compared to subjects in the placebo-supplementation group.  11 
 12 
Insert Tables 2 and 3 around here 13 
 14 
Attendance to the WP and the PAP 15 
Overall median attendance to the exercise programs (10
th
 –90
th
 percentile) was 63 (0-89) percent and 16 
did not differ between the WP and the PAP. Especially in the first weeks, a considerable number of 17 
subjects discontinued participation, mostly because they did not want to participate in the exercise 18 
programs after all. Most frequent reasons for discontinuation of the program after the first weeks were 19 
health-related problems. No adverse events of the WP or PAP itself were reported. Adherent subjects 20 
attending at least 75 percent of the sessions (n=51) were more often living together (82 versus 65 21 
percent, p=0.03) and less physically active than non-adherers (n=101), (median [10
th
 -90
th
 percentile] 22 
was 36 [13-82] versus 44 [10-169] minutes/day, p=0.02).  At baseline, adherers also had lower ratings 23 
of D-QoL-belonging (3.6 [0.41] versus 3.8 [0.49], p=0.02) and higher SF12-MCS values (56.5 [5.6] 24 
versus 53.7 [8.1], p=0.02). Other baseline and QoL characteristics did not differ significantly. 25 
 26 
Compliance with the (FA/B12/B6)supplementation 27 
Four participants did not return the blister packs. On the basis of pill counts in returned blister packs, 28 
median compliance (10
th
 –90
th
 percentile) with the FA/B12/B6-supplementation was 100 (97-100) 29 
percent and compliance with placebo-supplementation was 100 (35-100) percent. Even though 30 
median compliance in both groups was 100 percent, compliance in the placebo-group was 31 
 9 
significantly lower (p<0.05). Eight subjects, one in the FA/B12/B6-group and seven in the placebo-1 
group, did not take (vitamin)supplementation. Seven of them decided immediately after randomization 2 
not to participate in the interventions. The other wanted to participate in the exercise intervention only. 3 
Two participants discontinued taking vitamin pills during the trial after reporting sleep problems and 4 
increased forgetfulness; one participant discontinued taking the placebo pills after reporting not feeling 5 
well.    6 
 7 
Modified intention to treat analyses 8 
Results of the walking program and FA/B6/B12 supplementation are presented in table 4. With respect 9 
to overall QoL, no positive significant main effect of the WP or FA/B6/B12 supplementation was found. 10 
A significantly detrimental effect of FA/B6/B12 supplementation was observed on D-QoL-belonging, 11 
(beta (95%CI)= -0.18 (-0.29 ;-0.07), p<0.01). A positive interaction between the WP and attendance to 12 
the WP was observed on D-QoL-belonging and D-QoL-positive affect. With each percent increase in 13 
attendance, D-QoL-belonging increased with 0.003 points (p=0.04) and D-QoL-positive affect with 14 
0.002 points (p=0.06) in the WP compared to the PAP. With respect to health-related QoL, an 15 
interaction between the WP and gender was observed on the SF12-MCS (p=0.06) and therefore 16 
analysis for the SF12-MCS was stratified for gender. No main effects of the WP or FA/B12/B6-pills 17 
were observed. However, in men in the WP, SF12-MCS increased with 0.03 points with each percent 18 
increase in attendance (p=0.08).  19 
 20 
Insert Table 4 around here 21 
 22 
Per protocol analyses 23 
Subgroup analyses were performed in subjects attending 75 percent or more of the WP or PAP 24 
sessions (n=51, 33 men and 18 women). No between group differences were observed for 25 
FA/B12/B6-pills versus placebo-pills. A significant positive effect of the WP compared to the PAP was 26 
observed on D-QoL-positive affect, beta (95%CI)= 0.23 (0.06;0.39), p<0.01 and a borderline 27 
significant positive effect on D-QoL-self esteem, beta (95%CI)= 0.17 (0.001;0.34), p=0.05.  28 
 29 
 10 
Discussion 1 
No positive main effect of walking or daily FA/B6/B12 supplementation was observed on QoL in 2 
community-dwelling adults with MCI. However, ratings of overall QoL (i.e. feelings of belonging, 3 
positive affect) and the mental component of health-related QoL improved slightly with increasing 4 
attendance to the walking program. In a subgroup that attended at least 75 percent of the sessions, a 5 
beneficial effect of the walking program was observed on positive affect and self esteem.  6 
 7 
To our knowledge, this is the first intervention study on QoL in community-dwelling adults with MCI. 8 
While memory complaints are reported to be negatively associated with QoL in healthy older adults 9 
with subjective memory complaints [2], QoL ratings in our study population were already quite high at 10 
baseline. Baseline ratings on the DQOL sumscore and subscales fell ample above the midpoint of the 11 
scale, except for negative affect. Baseline scores on the SF-12MCS fell around a half standard 12 
deviation above the average in the general  population and SF-12PCS fell about the average ratings. 13 
QoL-ratings have been reported to decrease as the severity of cognitive decline increases [23]. The 14 
possibility exists that MCI as operationalised in the present study may not have been serious enough 15 
to negatively influence overall and health-related QoL. In spite of the high baseline values, the QoL 16 
scales still allowed for further improvements, i.e. there was no ceiling effect. However, it has been 17 
discussed before that QoL may represent a stable concept which is difficult to change or that existing 18 
measures may not be responsive to subtle changes [24]. 19 
 20 
The relationship between physical activity and QoL has been studied extensively. However, it is 21 
difficult to draw a clear conclusion, since various definitions and operationalisations of QoL circulate. 22 
Moreover, comparisons between studies are being complicated by the wide variety of study 23 
populations and features of exercise intentions such as intensity, exercise mode, frequency and 24 
session and total duration [25]. However, Rejeski et al. [26] concluded in a review including 28 studies, 25 
of which 11 RCT’s, that physical activity positively influenced aspects of health-related QoL. In a 26 
recent meta-analysis of Netz et al. [7] including 36 studies, a small positive effect of exercise was 27 
observed on wellbeing in healthy older adults. In that meta-analysis four components of wellbeing 28 
were considered, including aspects that were also measured in the FACT-study, such as positive and 29 
negative affect, perception of physical fitness and physical symptoms.  30 
 31 
 11 
In the present study no main effects of the WP were observed in the modified intention to treat 1 
analyses. First, a possible explanation for the lack of effect may be that only participants with good 2 
QoL were able to attend enough sessions. In contrast to an earlier study, no baseline differences in 3 
number of chronic diseases, physical health-related QoL and endurance were observed between 4 
adherers (attending ≥ 75 percent of the sessions) and non-adherers (attending < 75 percent of the 5 
sessions) [27]. However, adherers rated their mental health-related QoL at baseline significantly better 6 
than non-adherers. The difference was three points, which approximately equaled a difference of five 7 
percent. The possibility exists that subjects with lower mental health-related QoL were inclined to 8 
attend less sessions. Nevertheless, it is not likely that this biased our results, because non-adherers 9 
and drop-outs from the exercise programs were included in the modified intention to treat analyses. In 10 
future studies in subjects with cognitive decline, session attendance may be improved by informing 11 
subjects extensively about the study aims and the consequences of participation. Moreover, if possible 12 
with respect to logistic and financial issues, we advice to schedule time and staff for the close personal 13 
follow-up of temporary drop-outs. 14 
 15 
Second, it has been reported that the association between physical activity and QoL is lower among 16 
older adults who function at or above the norm [26]. By applying inclusion criteria for the present trial 17 
(e.g. community dwelling, no ADL disabilities, being able to perform moderate intensity physical 18 
activity), we presumably selected physically healthy and active subjects. This is supported by the high 19 
baseline activity levels. Two-thirds of the participants reported to be physically active at moderate 20 
intensity for thirty minutes or more per day. Subjects meeting this guideline are reported to have better 21 
health-related QoL than physically inactive adults [8]. Additionally, Netz et al. found that larger effects 22 
of exercise on wellbeing were observed in sedentary adults [7]. However, in the present study, no 23 
interaction between the walking program and baseline physical activity level was observed (results not 24 
presented), indicating that inactive participants did not benefit more from the WP than active 25 
participants. Therefore, it is not likely that baseline physical activity level was a main cause of the lack 26 
of main effects.  27 
 28 
Finally, inconclusive evidence is available about the intensity and exercise mode of physical activity 29 
required to benefit QoL. Netz et al. [7] concluded that aerobic training of moderate intensity was most 30 
beneficial for wellbeing. In a cross-sectional study, it was also observed that moderate intensity 31 
 12 
physical activity was positively related to health-related QoL [8]. In contrast, in a review by Spirduso 1 
and Cronin [28] no evidence of a relationship between exercise intensity and the rate of improvement 2 
in QoL was found. If the former would be true, the possibility exists that the contrast between both 3 
programs in the present study would not have been large enough to induce differences in QoL. If the 4 
latter would be true, participants would have benefited from participation in both exercise programs 5 
regardless of intensity. Both programs may either have added to better self-efficacy, or may prevented 6 
a decline in self-efficacy. The walking program by training cardiovascular endurance; the placebo 7 
activity program by training e.g. balance and ADL. Self-efficacy refers to somebody’s belief that one 8 
has the capabilities to successfully manage situational demands and is mentioned to be a mediating 9 
mechanism for the effect of physical activity on QoL [7, 25, 29, 30]. Thus, the presence of the low 10 
intensity placebo activity program in our study may have contributed towards the lack of between 11 
group differences. 12 
 13 
Nevertheless, several outcomes improved with increasing attendance to the walking program. In the 14 
per protocol analyses a beneficial effect was observed on positive affect. Self esteem also tended to 15 
improve. However, observed differences were small and approximated five percent differences from 16 
baseline QoL ratings. As a rule of thumb, a minimal change of five percent has been mentioned to 17 
signify clinical relevance. To obtain a change of five percent by increasing attendance, the required 18 
increase in attendance would be 62 percent for D-QoL-belonging and 94 percent for D-QoL-positive 19 
affect and the SF12-MCS. Therefore, it can be questioned whether the observed effects are clinically 20 
relevant. 21 
 22 
No effect of the FA/B12/B6 supplementation was observed except for a negative effect on feelings of 23 
belonging. However, no theoretical rationale exists for this effect. Our findings are in line with previous 24 
RCT’s on the effect of vitamin B supplementation on aspects of QoL. Deijen et al. [11] observed no 25 
effect of supplementation with 20 mg vitamin B6 for three months on mood in healthy men (n=76). 26 
Also no effect of supplementation with 750 mug folate, 15 mug vitamin B12 or 75 mg vitamin B6 daily 27 
for 35 days was observed on mood in women aged 65 or over (n=75) [11]. Finally, no effect on health-28 
related QoL was observed of a weekly injection with 1 mg vitamin B12 for four weeks in adults with 29 
vitamin B12 deficiency (n=140) [13]. These findings may find its origin in the used operationalisations 30 
 13 
and measures of QoL that include very few items that directly relate to nutrition. Amarantos et al. [31]  1 
underline the need to develop QoL measures including items that relate nutrition to QoL.   2 
 3 
To conclude, the walking program and vitamin B supplementation were not effective in improving QoL 4 
in community-dwelling older adults with MCI within one year. However, increasing attendance to 5 
moderate intensity physical activity may benefit certain aspects of QoL.   6 
 7 
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Figure 1: Flow chart. TI= Telephone Interview, WP= Walking Program, PAP= Placebo Activity Program, FA/B12/B6= Folic Acid, Vitamin B12, 
Vitamin B6 supplementation, SO= significant other, T6= follow-up after 6 months, T12= follow-up after 12 months, *reason for exclusion: only 
baseline data available. 
 18 
 
Table 1: Inclusion and exclusion criteria for participation in the trial  
Operationalisation of Petersen criteria for MCI (1-5) and additional inclusion criteria for the RCT (6-12) 
1. Memory complaints (answer yes to question ‘do you have memory complaints’, or at least twice sometimes at cognition scale of Strawbridge [32] 
2. Objective memory impairment; 10 WLT delayed recall ≤5 + percentage savings ≤ 100 [33] 
3. Normal general cognitive functioning; TICS ≥ 19 + MMSE ≥ 24 [34, 35] 
4. Intact daily functioning: no report of disability in activities of daily living on GARS-scale, except on the item ‘taking care of feet and toe nails’ [36] 
5. Absence of dementia; TICS ≥ 19 + MMSE ≥ 24 
6. Being able to perform moderate intensity physical activity, without making use of walking devices, e.g. a rollator or a walking frame  
7. Not using vitamin supplements/ vitamin injections/ drinks with dose of vitamin B6, B11 or B12 comparable to vitamin supplement given in intervention 
8. Not suffering from epilepsy, multiple sclerosis, Parkinson’s disease, kidney disorder requiring haemodialysis, psychiatric impairment 
9. Not suffering from depression as measured by the GDS (cut off ≤ 5) [37] 
10. Not using medication for rheumatoid arthritis or psoriasis interfering with vitamin supplement 
11. No alcohol abuse (men < 21 consumptions a week, women < 15 consumptions a week) 
12. Not currently living in a nursing home or on a waiting list for a nursing home 
MCI= Mild Cognitive Impairment, RCT= Randomized Controlled Trial, 10 WLT= 10 Word Learning Test, TICS= Telephone Interview for Cognitive Status, MMSE= 
Mini Mental State Examination, GARS= Groningen Activity Restriction Scale, GDS=Geriatric Depression Scale  
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Table 2: Baseline characteristics of participants (n=152) 
 Exercise intervention Vitamin intervention 
 WP (n= 77) PAP (n= 75) FA/B12/B6 (n= 78) Placebo-pill (n= 74) 
Age (Mean (SD)) 75 (2.9) 75 (2.8) 75 (2.8) 75 (2.9) 
Gender (% male) 48* 64 56 55 
MMSE (Median (10
th
 -90
th
 ‰)) 29 (26-30) 29 (27-30) 29 (25-30) 29 (27-30) 
Education (% low/middle/high)  61/22/17 52/29/19 57/26/17 55/26/19 
Marital status  (% living together) 75 68 69 73 
physical activity
1
 (min/day)  
(Median (10
th
 -90
th
 ‰)) 
44 (10-155) 39 (11-120) 45 (13-155) 38 (9-111) 
Vitamin status (% deficient FA/B12/B6)
 2
 46/8/0 48/8/0 49/9/0 45/7/0 
Homocysteine status 
3
 
(% hyperhomocysteinemia) 
27 23 27 23 
Blood pressure (% hypertension)
 4
 27* 14 25 16 
BMI (kg/m2)  (Median (10
th
 -90
th
 p‰)) 26.7 (23.1-31.5) 26.6 (23.5-32.7) 26.5 (23.3-32.8) 26.7 (23.5-31.2) 
Smoking (% smokers) 13 15 17 11 
Number of self-reported diseases (% 0,1,2)
 5
 52/42/6 69/27/4 66/28/6 55/41/4 
WP= Walking Program, PAP = Placebo Activity Program, FA/B12/B6= Folic Acid, Vitamin B12, Vitamin B6 supplementation, MMSE= Mini Mental State 
Examination, Education: low =no education, primary education, lower vocational training; intermediate = intermediate level secondary education, intermediate 
vocational training; high = higher level secondary education, higher vocational training, university training. BMI = Body Mass Index, 
1
 ≥ 3.0 metabolic equivalents,  
2 
cut off points: FA red blood cell < 337 nmol/L or FA plasma <6,3 nmol/l; B12 ≤ 150 pmol/ L; B6 < 20 nmol/L, 3 homocysteine > 14 mmol/L, 4 hypertension = 
diastole ≥ 90 and systole ≥ 160, 
5
 cardiovascular disease, chronic obstructive pulmonary disease, diabetes, epilepsy, multiple sclerosis, Parkinson’s disease, 
psychiatric disease, renal failure requiring dialysis and/or rheumatoid arthritis. * significantly different from PAP (p<0.05).
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Table 3: Means (standard deviations) of QoL ratings at baseline and after six and 12 months in older adults with MCI
1
. 
 
MCI= Mild Cognitive Impairment, WP= Walking Program, PAP = Placebo Activity Program, FA/B12/B6= Folic Acid, Vitamin B12, Vitamin B6 supplementation, D-
QoL= Dementia Quality of Life, SF12-MCS = Short Form 12 Mental Component Summary, SF12-PCS = Short Form 12 Physical Component Summary.
 1 
higher 
rating indicates better QoL, * p<0.05 (difference between FA/B12/B6 and placebo).  
 WP  PAP  FA/B12/B6  Placebo  
 T0 (n=77) T6 (n=77) T12 (n=71) T0 (n=75) T6 (n=75) T12 (n=67) T0 (n=78) T6 (n=78) T12 (n=71) T0 (n=74) T6 (n=74) T12 (n=67) 
D-QoL sumscore 3.5 (0.26) 3.5 (0.29) 3.5 (0.27) 3.5 (0.32) 3.5 (0.34) 3.5 (0.34) 3.5 (0.32) 3.5 (0.32) 3.5 (0.33) 3.4 (0.24) 3.5 (0.31) 3.5 (0.27) 
D-QoL aesthetics 3.5 (0.63) 3.5 (0.64) 3.6 (0.60) 3.5 (0.70) 3.5 (0.71) 3.5 (0.65) 3.5 (0.64) 3.5 (0.68) 3.6 (0.61) 3.4 (0.68) 3.5 (0.67) 3.6 (0.64) 
D-QoL belonging 3.7 (0.50) 3.7 (0.49) 3.7 (0.44) 3.8 (0.45) 3.7 (0.47) 3.7 (0.46)  3.8 (0.50) 3.6  (0.50) 3.6 (0.48) 3.7 (0.44) 3.8 (0.45) 3.8 (0.40) 
D-QoL negative affect 2.7 (0.45) 2.7 (0.46) 2.8 (0.50) 2.7 (0.55) 2.8 (0.54) 2.8 (0.52) 2.7 (0.54) 2.8 (0.47) 2.8 (0.53) 2.7 (0.47) 2.7 (0.53) 2.8 (0.49) 
D-QoL positive affect 3.8 (0.39) 3.7 (0.46) 3.8 (0.40) 3.8 (0.40)      3.7 (0.44) 3.8 (0.43) 3.8 (0.41) 3.7 (0.47) 3.8 (0.44) 3.8 (0.39) 3.8 (0.43) 3.8 (0.39) 
D-QoL self esteem 3.6 (0.45) 3.8 (0.41) 3.8 (0.40) 3.7 (0.48) 3.7 (0.49) 3.8 (0.48) 3.8 (0.48)* 3.8 (0.48) 3.9 (0.48) 3.6 (0.43) 3.7 (0.43) 3.7 (0.38) 
SF12-MCS 54.6 (6.85) 55.6 (6.40) 55.3 (4.39) 54.7 (8.07) 55.0 (7.34) 55.3 (6.24) 55.5 (7.49) 55.9 (6.91) 55.8 (4.90) 53.8 (7.36) 54.6 (6.86) 54.8 (5.76) 
SF12-PCS 48.2 (7.15) 48.1 (7.57) 50.5 (6.13)  48.7 (7.86) 48.8 (8.47) 49.8 (7.04) 47.9 (8.20) 47.4 (8.79) 49.8 (6.68) 49.1 (6.67) 49.6 (7.00) 50.6 (6.49) 
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Table 4: results of longitudinal multi level analyses on the effect of the WP and FA/B6/B12 supplementation on change in QoL (adjusted model)  
 
 
 
 
 
 
 
 
 
 
 
 
WP= Walking Program, PAP = Placebo Activity Program, FA/B12/B6= Folic Acid, Vitamin B12, Vitamin B6 supplementation, D-QoL= Dementia Quality of Life, 
SF12-MCS = Short Form 12 Mental Component Summary, SF12-PCS = Short Form 12 Physical Component Summary. * Interaction WP and gender 
 
 WP versus PAP 
Beta (95%CI) 
 
p-value 
FA/B12/B6 versus placebo 
Beta (95%CI)                  
 
p-value 
D-QoL sumscore 0.04 (-0.03 ;0.10) 0.25 -0.06 (-0.12;0.004)  0.07 
D-QoL aesthetics 0.06 (-0.07 ;0.20) 0.37 -0.07 (-0.20;0.07) 0.33 
D-QoL belonging 0.00 (-0.11;0.11) 0.96 -0.18 (-0.29 ;-0.07) 0.00 
D-QoL negative affect -0.02 (-0.12;0.08) 0.65 0.04 (-0.05 ;0.14) 0.37 
D-QoL positive affect 0.04 (-0.04 ;0.13) 0.34 -0.04 (-0.12 ;0.04) 0.33 
D-QoL self esteem 0.08 (-0.02;0.18) 0.11 0.00 (-0.10 ;0.11) 0.94 
SF12-PCS 0.66 (-1.23;2.54) 0.49 -0.73 (-2.65;1.19) 0.45 
SF12-MCS* men -0.82 (-2.24 ;0.60) 0.25 0.25 (-1.31;1.81) 0.76 
 women 1.66 (-1.50;4.81) 0.30 1.32 (-1.93;4.56) 0.42 
